Fernanda de Souza

Prof. Dr. Fernanda de Souza

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YSYngrid Mickaelli Oliveira dos Santos
Yngrid Mickaelli Oliveira dos Santos
IMIgor Santana de Melo
Igor Santana de Melo
APAmanda Larissa Dias Pacheco
Amanda Larissa Dias Pacheco
MRMilenna Maria Jatoba Hasten Reiter
Milenna Maria Jatoba Hasten Reiter
MCMaisa de Araújo Costa
Maisa de Araújo Costa
Olagide Wagner de CastroOlagide Wagner de Castro
Olagide Wagner de Castro

24 September 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
IMIgor Santana de Melo
Igor Santana de Melo
RSRobinson Sabino-Silva
Robinson Sabino-Silva
MCMaisa Araújo Costa
Maisa Araújo Costa
EVEmília Rezende Vaz
Emília Rezende Vaz
CACassius Iury Anselmo-E-Silva
Cassius Iury Anselmo-E-Silva
Olagide Wagner de CastroOlagide Wagner de Castro
Olagide Wagner de Castro

24 September 2026 in COVID
Verified
Journal Article
Open access
PDF file
MHMércia Thaisa Araújo Costa Homero
Mércia Thaisa Araújo Costa Homero
EFElaine dos Santos Farias
Elaine dos Santos Farias
FSFernanda de Souza Silva
Fernanda de Souza Silva
DLDomenico Lopes
Domenico Lopes
SASarah Alves de Assis
Sarah Alves de Assis
Olagide Wagner de CastroOlagide Wagner de Castro
Olagide Wagner de Castro
Coronavirus disease 2019 (COVID-19) has been associated with sexual and reproductive disturbances, but whether these findings reflect transient systemic illness or persistent dysfunction remains uncertain. We systematically searched PubMed, Scopus, Web of Science, Virtual Health Library, World Health Organization Global Index Medicus, and Embase for human studies published from 2020 through 2025, supplemented by ResearchRabbit citation- and similarity-based screening; the final update was performed in June 2026. Eligible studies assessed sexual, reproductive, psychological/behavioral, or biological outcomes in individuals with acute or post-COVID-19 conditions. Three reviewers independently extracted and verified data, using design-specific National Institutes of Health, Joanna Briggs Institute, and Mendelian-randomization-specific frameworks to assess risk of bias. Because of substantial clinical and methodological heterogeneity, results were synthesized narratively. The final synthesis included 218 eligible reports, corresponding to 214 conservative study/cohort units after confirmed companion/derived-publication linkage. Erectile dysfunction was the most consistent sexual outcome, whereas reproductive studies mainly reported reduced semen quality and alterations in testosterone and gonadal-axis markers, often appearing short-term. Inflammatory, oxidative, endocrine, vascular, histopathological, molecular, and psychosocial findings supported a multidimensional framework. However, the evidence was predominantly male-focused, observational, and heterogeneous, limiting causal and long-term inference. COVID-19 may affect sexual and reproductive health through interacting biological and psychosocial pathways, but persistent infertility or definitive reproductive impairment remains unconfirmed. The protocol was not registered; no specific external funding was received.